SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
FMC Corp revised third-quarter revenue and Adjusted EBITDA estimates downward and announced $625 million to $675 million in charges to lower channel i...
CMC reported record fiscal 2026 earnings of $655.8M driven by steel group growth. Net leverage dropped to below 2x, signaling strong operational execu...
Updated investor presentation outlines clinical programs and anticipated regulatory filings for its ophthalmology gene therapy candidates, emphasizing...
SurgePays, Inc. released its financial results for the first quarter of 2025, announcing its board approved a quarterly distribution of $0.10 per comm...
Bank7 Corp. reported a 22.25% increase in quarterly net income to $10.2 million, driven by loan growth and high capital levels. The bank also reported...
Jasper Therapeutics has completed the enrollment of the first IgAN cohort of its Phase 2 study evaluating vensobafusp alfa. The company anticipates re...
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Aurora Investment Managers, LLC.....
ManpowerGroup achieved strong top-line growth in Q3 driven by the U.S. brand, with Experis trending positive for the first time. The company confirmed...
The Allstate Corporation reported $220 million in September catastrophe losses for a third-quarter total of $1.65 billion. This loss is a primary oper...
ManpowerGroup names Becky Frankiewicz as chief executive officer effective Jan. 1, 2027, succeeding Jonas Prising, who will become executive chair. Th...
First Horizon reported a Q3 2026 net loss of $(0.20) per share due to notable items, but exited the period entering a $4.5 billion noncore asset sale ...
On May 23, Gibraltar Industries announced a definitive agreement to acquire a 30% stake in The D.S. Brown Co. and The D.S. Brown Valves subsidiary fro...
Plug Power reported continued Q3 business progress with significant margin improvements and notable net cash usage reduced to approximately $28 millio...
Cleared for final review, Aquestive Therapeutics received a March 16, 2027, FDA decision date for Anaphylm. The drug aims to be the first oral rescue ...
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Alhambra Investment Management LLC....
Institutional holdings report (13F-HR) for the period ended 2026-09-30 filed by Kentucky Trust Co....
Kimberly-Clark issued preliminary Q3 data showing organic sales growth of approx. 110 basis points below category growth due to China disruptions. The...
Sempreon, Inc. filed an amended and restated articles of incorporation to authorize stock structure. This regulatory filing details the authority for ...
Krystal Biotech reported that KB113 demonstrated over 80% regression of basal cell carcinomas in patients with Gorlin syndrome, showing a systemic imm...
Cronos Group intends to complete its acquisition of CanAdelaar B.V. by waiving conditions, pending Minister approval and adjusting the transaction ter...